Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Feasibility of Peripheral Blood Stem Cell Collection from Heterozygoussickle Cell Trait Donors

Juergen Foell, MD, Morad Morez, Anja Troeger, MD, Katharina Kleinschmidt, MD PhD, Beatrix Pfirstinger, Andreas Brosig, MD PhD, Ralph Burkhardt, MD PhD, Selim Corbacioglu, MD, Norbert Ahrens

Blood (2019) 134 (Supplement_1): 1171.

https://doi.org/10.1182/blood-2019-131984

Published: 2019

Journal Articles

CD34 + Donor Chimerism and Wilms Tumor Gene 1 (WT1) Expression Provide an Early Indication of Relapse in Patients with Acute Leukemias and MDS after Hematopoietic Cell Transplantation (HCT) with Reduced-Intensity Conditioning.

Max Hubmann, Ralph Burkhardt, Georg Franke, Michael Cross, Markus Scholz, Sabine Leiblein, Joachim Thiery, Dietger W. Niederwieser, Thoralf Lange

Blood (2006) 108 (11): 548.

https://doi.org/10.1182/blood.V108.11.548.548

Published: 2006

Journal Articles

Phlebotomy as an Effective Treatment for Iron Overload after Allogeneic Hematopoietic Cell Transplantation: Iron Depletion Kinetics Are Influenced by the Donor Hemochromatosis (HFE) Genotype.

Ann-Kathrin Eisfeld, Medical Student, Ralph Burkhardt, MD, Sabine Schroeder, MD, Rainer Krahl, PhD, Elvira Edel, MD, Christa Doering, Dietger Niederwieser, MD, Haifa K. Al-Ali, MD

Blood (2005) 106 (11): 3717.

https://doi.org/10.1182/blood.V106.11.3717.3717

Published: 2005

Journal Articles

Iron Overload Strongly Correlates with Acute Graft-Versus-Host-Disease of the Liver and Treatment Related Mortality after Allogeneic Hematopoetic Cell Transplantation (HCT).

Ann-Kathrin Eisfeld, Ralph Burkhardt, MD, Daniel Teupser, MD, Sabine Schroeder, MD, Rainer Krahl, PhD, Andrea Junghans, Elvira Edel, MD, Christa Doehring, Uwe G. Liebert, MD, Dietger W. Niederwieser, MD, Haifa K. Al-Ali, MD

Blood (2005) 106 (11): 1812.

https://doi.org/10.1182/blood.V106.11.1812.1812

Published: 2005

Journal Articles

HFE Genotype Is of Donor Origin and Does Not Correlate with Iron Overload Present in Patients after Allogeneic Stem Cell Transplantation.

Ann-Kathrin Eisfeld, Ralph Burkhardt, MD, Daniel Teupser, MD, Sabine Schroeder, MD, Rainer Krahl, PhD, Andrea Junghans, Elvira Edel, MD, Christa Doehring, Joachim Thiery, MD, Dietger W. Niederwieser, MD, Haifa K. Al-Ali

Blood (2004) 104 (11): 3684.

https://doi.org/10.1182/blood.V104.11.3684.3684

Published: 2004

NARROW

Feasibility of Peripheral Blood Stem Cell Collection from Heterozygoussickle Cell Trait Donors

CD34 + Donor Chimerism and Wilms Tumor Gene 1 (WT1) Expression Provide an Early Indication of Relapse in Patients with Acute Leukemias and MDS after Hematopoietic Cell Transplantation (HCT) with Reduced-Intensity Conditioning.

Phlebotomy as an Effective Treatment for Iron Overload after Allogeneic Hematopoietic Cell Transplantation: Iron Depletion Kinetics Are Influenced by the Donor Hemochromatosis (HFE) Genotype.

Iron Overload Strongly Correlates with Acute Graft-Versus-Host-Disease of the Liver and Treatment Related Mortality after Allogeneic Hematopoetic Cell Transplantation (HCT).

HFE Genotype Is of Donor Origin and Does Not Correlate with Iron Overload Present in Patients after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Feasibility of Peripheral Blood Stem Cell Collection from Heterozygoussickle Cell Trait Donors

CD34 + Donor Chimerism and Wilms Tumor Gene 1 (WT1) Expression Provide an Early Indication of Relapse in Patients with Acute Leukemias and MDS after Hematopoietic Cell Transplantation (HCT) with Reduced-Intensity Conditioning.

Phlebotomy as an Effective Treatment for Iron Overload after Allogeneic Hematopoietic Cell Transplantation: Iron Depletion Kinetics Are Influenced by the Donor Hemochromatosis (HFE) Genotype.

Iron Overload Strongly Correlates with Acute Graft-Versus-Host-Disease of the Liver and Treatment Related Mortality after Allogeneic Hematopoetic Cell Transplantation (HCT).

HFE Genotype Is of Donor Origin and Does Not Correlate with Iron Overload Present in Patients after Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only